Joel M. Wallace’s Perspectives

24 total results. Page 2 of 2.

News
Mad Dash to Coronavirus Vaccine May Face Legal Hurdles
Alerts
FDA Rule Shifting Drugs to New Approval Pathway May Cause Continued Generics Delays
Alerts
Anticompetitive Patent-Listing Decision May Clear Patent Thicket for Generic Pharma Industry
News
What if Pfizer Could Donate Data to NIH? One Proposal to Promote Public Good
News
Aly and Wallace Join Biosimilars Podcast on “Pay-for-Delay”
News
Wallace Quoted on Generic Drug Disruptions Due to Government Shutdown
Alerts
How Pharmaceutical Companies Can Navigate FDA During Shutdown
Press Release
Schiff Hardin Elects 10 New Partners
Press Release
Schiff Hardin Secures Patent Infringement Win
News
Wallace Quoted on Impact of ACA Ruling on Biosimilars Industry
Alerts
U.S. Pharmaceutical and Biologics Industries Could See Steep Potential Consequences from Texas Judge’s ACA Decision
Alerts
Pharmaceutical and Technology Industry Innovation Growth at Stake in Helsinn Healthcare v. Teva